logo

For the Inventor, By the Inventor

Paris, France

Exonhit Therapeutics, Sa


USPTO Granted Patents = 25

% Expired Patents = 40.0


Forward Citations = 82

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Bertrand Leblond (13 out of 23 patents)

silverMedal John E Donello (12 out of 136 patents)

bronzeMedal Thierry Taverne (11 out of 16 patents)

4.  Fabien J Schweighoffer (10 out of 21 patents)

5.  Eric Beausoleil (9 out of 16 patents)

6.  Laurent Bracco (6 out of 9 patents)

7.  Laurent Desire (5 out of 6 patents)

8.  Matthew P Pando (5 out of 5 patents)

9.  Bruno Tocque (5 out of 15 patents)

10.  Rong Yang (4 out of 29 patents)

11.  Anne-Sophie Casagrande (4 out of 5 patents)

12.  Cedric Chauvignac (3 out of 3 patents)

13.  Eric Beusoleil (2 out of 3 patents)

14.  Lauren M Luhrs (2 out of 8 patents)

15.  Annelies Resink (2 out of 2 patents)


Core Competencies:
PDE Inhibitors
Analgesics
Cognitive Disorders
Immunostimulant Activity
Alzheimer's Disease
Cell Proliferative Diseases
Retinopathies
Genetic Markers
Molecular Targets
Differential Screening
Prostate Cancer
Ocular Pathologies

25 patents:

1. 9902710 - Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) (2018-02-27),
2. 9828349 - 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity (2017-11-28),
3. 9670181 - Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) (2017-06-06),
4. 9278943 - Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds (2016-03-08),
5. 9200016 - Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) (2015-12-01),
6. 8835463 - Compounds having analgesic and/or immunostimulant activity (2014-09-16),
7. 8772316 - Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) (2014-07-08),
8. 8629165 - Methods for treating cognitive disorders (2014-01-14),
9. 8513288 - 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity (2013-08-20),
10. 8481701 - Process and method for diagnosing Alzheimer's disease (2013-07-09),
11. 8431599 - 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity (2013-04-30),
12. 8288556 - 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity (2012-10-16),
13. 8173683 - Methods for treating cognitive disorders (2012-05-08),
14. 8003375 - Qualitative differential screening (2011-08-23),
15. 7923579 - Tricyclic hydroxamate and benzamide derivatives, compositions and methods (2011-04-12),
Company Overview
Exonhit Therapeutics, based in Paris, specializes in the development of innovative diagnostic solutions and therapeutic products, primarily focusing on oncology and neurodegenerative diseases. The company leverages advanced genomic technologies to enhance patient care through personalized medicine. With a commitment to research and development, Exonhit aims to address unmet medical needs by providing tools that facilitate early detection and effective treatment strategies, thereby improving patient outcomes in critical health areas.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

25 Patents

#203 in Paris

#842 in France

#25,730 in the World

Paris, FR
Paris, France

Exonhit Therapeutics, Sa

Forward Citations = 82

32 inventors:

goldMedal Bertrand Leblond (13 out of 23 patents)

silverMedal John E Donello (12 out of 136 patents)

bronzeMedal Thierry Taverne (11 out of 16 patents)

4.  Fabien J Schweighoffer (10 out of 21 patents)

5.  Eric Beausoleil (9 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Exonhit Therapeutics, Sa. Retrieved from https://idiyas.com/company/exonhit-therapeutics-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…